About Ulrik Nielsen
Ulrik Nielsen is a director at Alloy Therapeutics.
Ulrik Nielsen first appears on SEC filings in 2021.
Experience
This experience comes from Ulrik Nielsen's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ulrik Nielsen in the role, so the role may have started earlier or lasted longer.
MT
Madeleine Therapeutics Current
Member Board of Directors
2026 – Present
MB
Mission BioCapital Current
General Partner
2025 – Present
TT
TROYA Therapeutics Current
Co-Founder and Executive Chairman
2024 – Present
VT
Volnay Therapeutics Current
Co-founder and Chairman
2023 – Present
Alloy Therapeutics, Inc. Current
Member Board Of Directors
2019 – Present · Waltham, MA
Drug discovery platforms and development services for biotech companies, pharmaceutical firms and academic researchers.
NT
Notch Therapeutics
Chairman Of The Board
2018 – 2025
MP
Merrimack Pharmaceuticals
Member Board of Directors
2002 – 2024
TT
Tidal Therapeutics
Co-founder, President and CEO, Tidal Therapeutics (a Sanofi company)
2019 – 2023
TM
Torque (now Repertoire Immune Medicines)
Founder Chairman and President
2015 – 2018
SI
Silver Creek Pharmaceuticals, Inc.
CEO
2010 – 2014
MI
MIT
Postdoc
2000 – 2002
UF
University of California, San Francisco
Postgraduate Researcher
1996 – 2000
Key Colleagues at Startups
The people Ulrik Nielsen works with at each company, as listed on that company's latest Form D.
Alloy Therapeutics, Inc. · Form D, Apr 15, 2026
AS
Anthony Sun
Director
AH
Alaa Halawa
Director
JC
Jason Camm
Director
JC
Jason Coloma
Director
CK
Christian Kanady
Director
AK
Alex Kolicich
Director
Errik Anderson
Founder, CEO, Chairman of Alloy
Piotr Bobrowicz
Chief Scientific Advisor and director
LS
Logan Snyder
Director